Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People under 50 who were cured of hepatitis C were at comparable risk to the general population.
With interferon quickly becoming a thing of the past, what kind of side effects still remain in the new hepatitis C regimens?
Those with early cirrhosis, hoping to stall further deterioration don’t have the luxury of time.
“This is a very significant advance.”
BMS has submitted for approval in Japan daclatasvir and asunaprevir as the world’s first interferon- and ribavirin-free hep C treatment.
Gilead Sciences has planned a $47 million expansion of its Canadian pharmaceutical plant after its hepatitis C drug sofosbuvir moved closer to...
New hep C drugs are likely hitting the market in the very near future. But how long until interferon can be sent packing?
Faldaprevir and deleobuvir, plus ribavirin, cured genotype 1 of hepatitis C virus (HCV) in 52 to 69 percent of study participants in a recent...
Preparing for a great revolution in hepatitis C care, major pharmaceutical companies are in a mad dash toward achieving blockbuster status.
A cheap, generic anti-viral. It turns out that even with all the advances drug makers are realizing in interferon-free drug combinations, riba...
Promising Phase III results from a trial of Gilead Sciences’s hepatitis C antiviral sofosbuvir open the door for regulatory filing this...
The hepatitis C pipeline: huge changes on the horizon
Antiviral therapies faldaprevir and BI 207127 are safe and effective among people with hepatitis C virus, including those with advanced liver...
A combination of daclatasvir and sofosbuvir produced cures in more than 93 percent of hepatitis C patients, with or without the addition of ri...
Danoprevir and mericitabine, two experimental hepatitis C therapies, proved safe and effective among patients with previous treatment experien...
Abbott Laboratories’ three-drug regimen cured 97 percent of treatment-naive hepatitis C patients and 93 percent of those who had failed a prev...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.